| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |